Amalgamated Bank Cerus Corp Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Cerus Corp stock. As of the latest transaction made, Amalgamated Bank holds 6,045 shares of CERS stock, worth $10,820. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,045

Previous 6,045 -0.0%

Holding current value

$10,820

Previous $11,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.66 - $2.42 $31,770 - $46,316	-19,139 Reduced 76.0%	6,045 $11,000
Q4 2023 Feb 06, 2024	SELL	$1.25 - $2.35 $2,248 - $4,227	-1,799 Reduced 6.67%	25,184 $54,000
Q2 2023 Aug 11, 2023	BUY	$1.79 - $2.9 $5,069 - $8,212	2,832 Added 11.73%	26,983 $66,000
Q1 2023 May 02, 2023	SELL	$2.65 - $3.81 $9,595 - $13,796	-3,621 Reduced 13.04%	24,151 $72,000
Q3 2022 Nov 09, 2022	BUY	$3.43 - $5.83 $1,512 - $2,571	441 Added 1.61%	27,772 $100,000
Q2 2022 Aug 15, 2022	SELL	$4.41 - $5.69 $233 - $301	-53 Reduced 0.19%	27,331 $145,000
Q1 2022 Jun 30, 2022	SELL	$4.81 - $6.99 $11,120 - $16,160	-2,312 Reduced 7.79%	27,384 $150,000
Q4 2021 Feb 15, 2022	SELL	$5.97 - $7.93 $3,301 - $4,385	-553 Reduced 1.83%	29,696 $202,000
Q3 2021 Oct 29, 2021	SELL	$4.79 - $6.68 $7,256 - $10,120	-1,515 Reduced 4.77%	30,249 $184,000
Q2 2021 Aug 16, 2021	BUY	$5.35 - $6.35 $45,089 - $53,517	8,428 Added 36.12%	31,764 $188,000
Q1 2021 May 13, 2021	SELL	$5.68 - $7.87 $13,194 - $18,282	-2,323 Reduced 9.05%	23,336 $140,000
Q4 2020 Feb 12, 2021	BUY	$5.25 - $8.56 $666 - $1,087	127 Added 0.5%	25,659 $177,000
Q3 2020 Oct 30, 2020	SELL	$5.78 - $7.47 $1,554 - $2,009	-269 Reduced 1.04%	25,532 $160,000
Q2 2020 Aug 10, 2020	BUY	$4.5 - $7.02 $5,958 - $9,294	1,324 Added 5.41%	25,801 $170,000
Q1 2020 May 13, 2020	BUY	$2.87 - $5.49 $1,150 - $2,201	401 Added 1.67%	24,477 $114,000
Q4 2019 Feb 13, 2020	BUY	$3.84 - $4.86 $1,032 - $1,307	269 Added 1.13%	24,076 $102,000
Q3 2019 Nov 13, 2019	SELL	$4.86 - $6.05 $855 - $1,064	-176 Reduced 0.73%	23,807 $123,000
Q2 2019 Aug 14, 2019	BUY	$4.51 - $6.6 $17,417 - $25,489	3,862 Added 19.19%	23,983 $135,000
Q1 2019 May 15, 2019	BUY	$5.16 - $6.85 $3,534 - $4,692	685 Added 3.52%	20,121 $125,000
Q4 2018 Feb 15, 2019	BUY	$4.89 - $7.16 $95,042 - $139,161	19,436 New	19,436 $99,000
Q3 2018 Nov 14, 2018	SELL	$6.89 - $7.78 $133,796 - $151,079	-19,419 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$5.19 - $7.25 $12,263 - $17,131	2,363 Added 13.85%	19,419 $130,000
Q1 2018 May 22, 2018	BUY	$3.56 - $5.74 $6,116 - $9,861	1,718 Added 11.2%	17,056 $93,000
Q4 2017 Feb 13, 2018	BUY	$2.76 - $3.95 $6,651 - $9,519	2,410 Added 18.64%	15,338 $52,000
Q3 2017 Nov 09, 2017	BUY	$2.22 - $2.73 $28,700 - $35,293	12,928	12,928 $35,000

Others Institutions Holding CERS

# of Institutions

156

Shares Held

147M

Call Options Held

84.2K

Put Options Held

55.5K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Cerus Corp Transaction History